KDR and ovarian carcinoma: A study that measured VEGF-A values for 128 patients with ovarian cancer found that the values for stage I and II were statistically significantly lower than for stage III/IV (p = 0.0036), and that patients with increased VEGFR-2 values have a better prognosis than those with low values (HR = 2.01) [34].